We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
80+ Mutants From SARS-CoV-2 Variants of Concern
Product

80+ Mutants From SARS-CoV-2 Variants of Concern

80+ Mutants From SARS-CoV-2 Variants of Concern
Product

80+ Mutants From SARS-CoV-2 Variants of Concern

ACROBiosystems

After the sharp rise in COVID-19 cases and deaths in India over recent weeks, at least 20 countries have imposed travel bans and restrictions to and from India. The world again stands at a crossroad of the viral evolution.

Some preliminary studies yield necessary findings that may help prevent massive transmission of the variant. Certainly, to introduce appropriate public health interventions in the future, continuous genomic surveillance is needed to monitor the mutations on B.1.617 and other emerging variants of SARS-CoV-2.

ACROBiosystems has accelerated the development of a series of recombinant antigens of the SARS-CoV-2 Variants of Concern, including B.1.617, accordingly to help better understand the transmissibility and infectivity of the variant.

Featured Products
All critical mutations covered

  • Full length S trimer with multiple mutations
  • 6P and 2A mutations make the protein more stable
  • Suitable for antibody detection

    Relevant recommendation
    Broad-spectrum neutralizing antibody


    It is exciting that an anti-SARS-CoV-2 Spike RBD neutralizing antibody (Cat. No. S1N-M122) developed by ACROBiosystems retains potent neutralizing activity against popular SARS-CoV-2 variants as tested by pseudovirus assay. The broad-spectrum neutralizing antibody is suitable to be a positive control in neutralization antibody screening, QC test reagent for both recombinant protein vaccines and COVID-19 neutralizing antibody detection in vaccinated serum.

      Company Details
      ACROBiosystems
      1 Innovation Way
      Newark
      DE
      19711
      USA
      Tel: 1 800-810-0816
      Fax: 1 888-377-6111
      Advertisement